Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Current Deferred Revenue (2020 - 2025)

iHuman has reported Current Deferred Revenue over the past 6 years, most recently at $31.0 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 21.37% to $31.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.0 million through Dec 2025, down 21.37% year-over-year, with the annual reading at $31.4 million for FY2025, 18.96% down from the prior year.
  • Current Deferred Revenue was $31.0 million for Q4 2025 at iHuman, down from $39.4 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $53.3 million in Q4 2022 and troughed at $31.0 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $44.2 million (2023), against an average of $43.1 million.
  • Biggest five-year swings in Current Deferred Revenue: grew 16.92% in 2021 and later fell 21.37% in 2025.
  • Tracing IH's Current Deferred Revenue over 5 years: stood at $47.4 million in 2021, then rose by 12.47% to $53.3 million in 2022, then dropped by 16.98% to $44.2 million in 2023, then fell by 10.88% to $39.4 million in 2024, then decreased by 21.37% to $31.0 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $31.0 million, $39.4 million, and $44.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.